Abstract
Multiple sclerosis (MS) is a demyelinating disease that more commonly affects women; its occurrence is partially determined by ancestral background.
In patients with classic MS, hyperactivity of the hypothalamic-pituitary-adrenal axis and a chronically activated corticotropin-releasing hormone (CRH) system have been shown.
Neuromyelitis optica (NMO) spectrum disorder, also known as Devic’s disease, is a group of related demyelinating conditions with common manifestations in the suprasellar region and spinal cord. The optic chiasm, nerves, hypothalamus, and infundibulum are frequently affected. The spectrum of disease includes classic NMO, optic neuritis, Asian opticospinal MS, NMO with endocrinopathies, and other subtypes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ysrraelit MC, Gaitán MI, Lopez AS, Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology. 2008;71:1948–54.
Fassbender K, Schmidt R, Mössner R, Kischka U, Kühnen J, Schwartz A, Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol. 1998;55:66–72.
Huitinga I, Erkut ZA, van Beurden D, Swaab DF. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol. 2004;55:37–45.
Storoni M, Davagnanam I, Radon M, Siddiqui A, Plant GT. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol. 2013;33:123–7.
Downer JJ, Leite MI, Carter R, Palace J, Küker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? Neuroradiology. 2012;54:279–85.
Whitham RH, Brey RL. Neuromyelitis optica: two new cases and review of the literature. J Clin Neuroophthalmol. 1985;5:263–9.
Baba T, Nakashima I, Kanbayashi T, Konno M, Takahashi T, Fujihara K, et al. Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. J Neurol. 2009;256:287–8.
Zhang Y, Dong R, Fan H, Li S, Geng D. Hypothalamus syndrome in opticospinal multiple sclerosis. AJNR Am J Neuroradiol. 2011;32:E153–5.
Suzuki K, Nakamura T, Hashimoto K, Miyamoto M, Komagamine T, Nagashima T, et al. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: a case report and literature review. Arch Neurol. 2012;69:1355–9.
Petravić D, Habek M, Supe S, Brinar VV. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome or just a coincidence? Mult Scler. 2006;12:670–3.
Vernant JC, Cabre P, Smadja D, Merle H, Caubarrère I, Mikol J, Poser CM. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology. 1997;48:58–64.
Hui AC, Wong RS, Ma R, Kay R. Recurrent optic neuromyelitis with multiple endocrinopathies and autoimmune disorders. J Neurol. 2002;249:784–5.
Yamasaki K, Horiuchi I, Minohara M, Osoegawa M, Kawano Y, Ohyagi Y, et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med. 2000;39:296–9.
Wang F, Liu Y, Duan Y, Li K. Brain MRI abnormalities in neuromyelitis optica. Eur J Radiol. 2011;80:445–9.
Qiu W, Raven S, Wu JS, Bundell C, Hollingsworth P, Carroll WM, et al. Hypothalamic lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:819–22.
Poppe AY, Lapierre Y, Melançon D, Lowden D, Wardell L, Fullerton LM, Bar-Or A. Neuromyelitis optica with hypothalamic involvement. Mult Scler. 2005;11:617–21.
O’Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, et al. Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996;60:382–7.
Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–12.
Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist. 2007;13:2–11.
Sato D, Callegaro D, Lana-Peixoto MA, Fujihara K, Brazilian Committee for Treatment and Research in Multiple Sclerosis. Treatment of neuromyelitis optica: an evidence based review. Arq Neuropsiquiatr. 2012;70:59–66.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zada, G., Lopes, M.B.S., Mukundan, S., Laws, E. (2016). Demyelinating Diseases: Multiple Sclerosis and Neuromyelitis Optica. In: Zada, G., Lopes, M., Mukundan Jr., S., Laws Jr., E. (eds) Atlas of Sellar and Parasellar Lesions. Springer, Cham. https://doi.org/10.1007/978-3-319-22855-6_58
Download citation
DOI: https://doi.org/10.1007/978-3-319-22855-6_58
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22854-9
Online ISBN: 978-3-319-22855-6
eBook Packages: MedicineMedicine (R0)